AACR 24: Cancer vaccines get a reintroduction as readouts support 'path forward' for the tech aarmstrong Tue, 04/09/2024 - 16:53
Alcanza acquires Innovation Medical Research Center location outside Miami hfloersh Tue, 04/09/2024 - 13:28
YS Biopharma's rabies vaccine bests approved competitor in interim phase 3 readout jwaldron Tue, 04/09/2024 - 10:06
Karuna's captains set sail in new neuropsychiatric venture called Seaport Therapeutics jwaldron Tue, 04/09/2024 - 08:26
BrainStorm, plotting Lazerus-like recovery, aligns with FDA on design of phase 3b ALS trial ntaylor Tue, 04/09/2024 - 07:52
Former bluebird execs hope to fly new startup to 'cutting edge' of gene therapy delivery tech hfloersh Mon, 04/08/2024 - 18:13
AACR 24: AstraZeneca next-gen PARP inhibitor gives 'bang for your buck' over firstcomers aarmstrong Mon, 04/08/2024 - 17:08
